ANGO Angiodynamics Inc
Price (delayed)
$10.98
Market cap
$444.31M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$5.57
Enterprise value
$390.22M
AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics' diverse product lines include
Highlights
ANGO's net income is up by 8% since the previous quarter
Angiodynamics's EPS has increased by 8% from the previous quarter
Angiodynamics's equity has plunged by 53% YoY and by 5% from the previous quarter
The quick ratio has decreased by 24% YoY and by 11% QoQ
Key stats
What are the main financial stats of ANGO
Market
Valuations
Earnings
Shares outstanding
40.47M
Market cap
$444.31M
Enterprise value
$390.22M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.39
Price to sales (P/S)
1.57
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.36
Revenue
$286.5M
Gross profit
$151.01M
Operating income
-$238.78M
Net income
-$224.72M
EBIT
-$238.36M
EBITDA
-$208.4M
Free cash flow
$2.65M
Per share
Balance sheet
Liquidity
EPS
-$5.57
EPS diluted
-$5.57
Free cash flow per share
$0.06
Book value per share
$4.6
Revenue per share
$7
TBVPS
$5.34
Total assets
$291.55M
Total liabilities
$104.78M
Debt
$0
Equity
$186.77M
Working capital
$86.77M
Debt to equity
0
Current ratio
1.98
Quick ratio
1.1
Net debt/EBITDA
0.26
Margins
Efficiency
Dividend
EBITDA margin
-72.7%
Gross margin
52.7%
Net margin
-78.4%
Operating margin
-83.3%
Return on assets
-73.2%
Return on equity
-111.3%
Return on invested capital
-303.7%
Return on capital employed
-117.4%
Return on sales
-83.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ANGO stock price
How has the Angiodynamics stock price performed over time
Intraday
-0.54%
1 week
-12.23%
1 month
20.93%
1 year
85.16%
YTD
19.87%
QTD
19.87%
Financial performance
How have Angiodynamics's revenue and profit performed over time
Revenue
$286.5M
Gross profit
$151.01M
Operating income
-$238.78M
Net income
-$224.72M
Gross margin
52.7%
Net margin
-78.4%
The revenue has declined by 13% year-on-year and by 2.1% since the previous quarter
ANGO's gross profit is down by 10% year-on-year
ANGO's net income is up by 8% since the previous quarter
The company's net margin rose by 6% QoQ
Growth
What is Angiodynamics's growth rate over time
Valuation
What is Angiodynamics stock price valuation
P/E
N/A
P/B
2.39
P/S
1.57
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.36
Angiodynamics's EPS has increased by 8% from the previous quarter
The P/B is 84% more than the last 4 quarters average of 1.3 and 71% more than the 5-year quarterly average of 1.4
Angiodynamics's equity has plunged by 53% YoY and by 5% from the previous quarter
The P/S is 74% more than the last 4 quarters average of 0.9 but 13% less than the 5-year quarterly average of 1.8
The revenue has declined by 13% year-on-year and by 2.1% since the previous quarter
Efficiency
How efficient is Angiodynamics business performance
The ROE is down by 17% since the previous quarter
ANGO's ROA is down by 8% since the previous quarter
ANGO's ROIC is down by 6% QoQ
Dividends
What is ANGO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ANGO.
Financial health
How did Angiodynamics financials performed over time
Angiodynamics's total assets is 178% higher than its total liabilities
Angiodynamics's total assets has decreased by 42% YoY
The quick ratio has decreased by 24% YoY and by 11% QoQ
The company's debt is 100% lower than its equity
Angiodynamics's equity has plunged by 53% YoY and by 5% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.